NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024Business Wire • 01/30/24
ROSEN, A LEADING NATIONAL FIRM, Encourages NeoGenomics, Inc. Investors to Inquire About Securities Class Action Investigation – NEOBusiness Wire • 01/02/24
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/02/24
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy ResponseAccesswire • 12/05/23
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare ConferenceAccesswire • 11/14/23
Wall Street Analysts See a 28.17% Upside in NeoGenomics (NEO): Can the Stock Really Move This High?Zacks Investment Research • 11/13/23
Compared to Estimates, NeoGenomics (NEO) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/07/23
NeoGenomics (NEO) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/30/23
Wall Street Analysts Think NeoGenomics (NEO) Could Surge 35.08%: Read This Before Placing a BetZacks Investment Research • 10/27/23
NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer PortfoliosAccesswire • 10/24/23
NeoGenomics (NEO) Soars 8.9%: Is Further Upside Left in the Stock?Zacks Investment Research • 10/18/23
NeoGenomics (NEO) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 10/13/23
NeoGenomics (NEO) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/08/23
NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast CancerAccesswire • 07/27/23
Investors Make A Bundle On 10 Stocks Others Panic Sold (Like Tesla)Investors Business Daily • 07/21/23
Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service DeliveryGlobeNewsWire • 07/18/23
NeoGenomics Expands Board of Directors with Appointments of Three Independent DirectorsAccesswire • 06/29/23